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The human U1 snRNP (small nuclear ribonucleopro-
tein), which is a part of the spliceosome, consists of U1
snRNA and ten different proteins: seven Sm proteins
B/B’, D1, D2, D3, E, F, and G and the three U1-specific
proteins U1–70 K, U1-A, U1-C. To determine the stoichi-
ometry of all ten proteins, the complex was denatured,
digested completely with an endoproteinase and labeled
with an amine-specific tag. Corresponding peptides
were synthesized and labeled with the same tag contain-
ing heavier isotopes. The digest was then spiked with
defined amounts of the synthetic peptides, and the re-
sulting isotopic peptide pairs were analyzed quantita-
tively by mass spectrometry. The mass spectra provided
information about the absolute amount of each compo-
nent in the starting protein mixture. The use of the
isotope-coded, amine-specific reagents propionyl-N-oxy-
succinimide and nicotinoyl-N-oxysuccinimide was eval-
uated for stoichiometry determination; the nicotinoyl
reagent was found to be advantageous because of its
greater mass spectrometric sensitivity. Absolute quan-
tities of all ten proteins were measured, showing equal
numbers of all ten proteins in the U1 spliceosomal
snRNP. These data demonstrate that quantitative mass
spectrometry has great potential for the determination
of the stoichiometry of multiprotein complexes.
Many cellular functions are regulated by multiprotein com-
plexes. Mass spectrometry-based methods have allowed signif-
icant advances in the discovery and identification of the inter-
acting proteins. Furthermore, this technique has also been
used to study the (relative) dynamics of protein complexes in
different states by the incorporation of stable isotopes (1, 2), a
method widely used in quantitative proteomics. Labeling with
stable isotopes can be achieved either by chemical modification
of side-chain amino groups with a reagent containing heavier
isotopes (2H, 13C, 15N) (3, 4) or by incorporation of isotope-coded
amino acids from the growth medium (5, 6). To understand the
function of individual proteins in a complex, it is necessary to
analyze the interacting proteins in a quantitative way, which
reveals whether a certain protein is present in defined stoichi-
ometric amounts or forms only a weak substoichiometric inter-
action. To gain a knowledge of the stoichiometry of a protein
complex, however, determination of the absolute amounts (7, 8)
of the complex constituents is required. We recently described
a method for the determination of the stoichiometry of protein
complexes, which is based on proteolytic digestion of the com-
plex, labeling with a fluorescent reagent specific for amino or
sulfhydryl groups, and separation by liquid chromatography
with fluorescence and mass-spectrometric detection. The
strength of the fluorescence signal of the labeled peptides from
different proteins is directly proportional to the stoichiometry
of these proteins in the complex (9). For large multiprotein
complexes, this method may be limited because of the difficulty
involved in the separation of very complex peptide mixtures;
poor resolution of these may lead to an overlap of the peptide
peaks in the fluorescence chromatogram, preventing correct
quantification. Here we describe the application of a similar
approach that overcomes this limitation.
We applied the new method to the determination of the
protein stoichiometry of the spliceosomal multiprotein complex
U1 snRNP. The spliceosome is formed by four small nuclear
ribonucleoproteins (snRNPs),1 U1, U2, U5, and U4/U6 (named
after their uridine-rich snRNAs) and numerous additional pro-
teins (10). The snRNPs can be divided into two groups: the
U-snRNP-specific proteins and the Sm proteins (11). The Sm
proteins, named SmB, SmD1, SmD2, SmD3, SmE, SmF, and
SmG, are associated with the Sm binding site of the snRNAs,
except for U6, which contains homologous “Sm-like” proteins.
Some arginine residues of SmB and SmD3 have symmetrical
dimethyl modifications (12). In humans, some tissues, as well
as HeLa cells, contain a second SmB protein called SmB,
which is a splicing variant in which the last two amino acid
residues are replaced by a new sequence of eleven residues (13).
When bound to the snRNA, the Sm proteins form a very stable
core RNP structure. In vitro, Sm proteins form specific protein
complexes, and crystal structures have been obtained from the
two dimeric SmD1/D2 and SmD3/B complexes. These results
prompted the proposal of a heptameric circular model for the
Sm core RNP (14). Furthermore, co-precipitation experiments
with genetically labeled yeast Sm proteins have suggested that
one copy of each Sm protein is present in the core RNP (15). U1
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snRNP, purified from HeLa cells, is the smallest and best
characterized human spliceosomal RNP subunit. Besides the
Sm proteins, it contains only three specific proteins: U1–70 K,
U1-A, and U1-C. Electron cryomicroscopy of U1 snRNP re-
vealed a three-dimensional structure consisting of a circular
core domain quite similar to the proposed heptameric Sm ring
structure and individual additional domains for U1–70 K and
U1-A proteins with sizes compatible with one copy of each of
these proteins (16). The U1-C protein could not be recognized
as an individual domain. Although these results suggested the
presence of one copy of U1-C, other biochemical experiments
suggested that U1-C in the U1 snRNP could be present as a
dimer (17).
For protein stoichiometry determination, up to three refer-
ence peptides were synthesized for each U1 snRNP protein and
were quantified and labeled with a [13C]-coded tag, whereas the
peptides derived from U1 snRNP proteolysis were labeled with
a [12C]-coded tag. Mass spectrometric analysis of mixtures of
both kinds of labeled peptides provided information about the
absolute quantities of the constituents of the U1 spliceosomal
snRNP.
EXPERIMENTAL PROCEDURES
Materials—Acetonitrile (gradient grade), urea (analytical grade), di-
thiothreitol, ammonium chloride, trifluoroacetic acid (TFA, analytical
grade), and guanidinium hydrochloride (analytical grade) were ob-
tained from Merck (Darmstadt, Germany). HEPES was obtained from
Sigma. Water from an ultrapure water system (Millipore, Bedford, MA)
was used for preparation of all aqueous solutions. Trypsin and endo-
proteinases Lys-C, Glu-C, and Asp-N were from Roche Applied Science
(Mannheim, Germany). Tri-isopropylsilane and Me2SO were obtained
from Fluka Sigma-Aldrich GmbH (Seelze, Germany), Fmoc amino acids
fromMultiSynTech GmbH (Witten, Germany), and NMM from Biosolve
BV (Valkenswaard, Netherlands).
Synthesis of Reference Peptides—Peptide synthesis was performed
using Fmoc chemistry (ByBop/NMM activation, Trt/tBu/Pbf/Boc side-
chain protection), preloaded Wang Resins (200–400 mesh) on a multi-
ple peptide synthesizer (AMS 422; Abimed GmbH) on a 20-mol scale.
The peptides were cleaved (92.5% TFA, 2.5% water, 5% tri-isopropylsi-
lane) for 1.5 h, precipitated, and washed three times with cold methyl
t-butyl ether. Air-dried crude peptides were purified using reversed-
phase HPLC (solvents, water-acetonitrile gradients, 0.1% TFA) (HPLC
system, Sycam GmbH), a GROM Sil ODS 2 column (25 cm length  2
cm diameter), and 5-m C18 silica beads. The purity of the peptide
fractions was assessed by analytical reversed-phase HPLC (solvents,
water-acetonitrile gradient) (HPLC system, Beckman System Gold), a
GE Healthcare SOURCE 5 RPC ST 4.6/150 column (15 cm length  4.6
mm diameter), and 5-m C18 polystyrene/divinylbenzene beads. The
sequence identity of the peptides was verified by MALDI-TOF mass
spectrometry. Absolute quantification of the reference peptide amounts
was performed gravimetrically (accuracy 0.05 mg), carefully minimiz-
ing errors caused by peptide hygroscopy or electrostatic effects of the
sample cup.
Labeling of the Peptides with [13C]Propionyl-N-oxysuccinimide or
[13C]Nicotinoyl-N-oxysuccinimide—0.8–6 mg of the reference peptides
were dissolved in 1 ml of 10% acetonitrile or 10% acetonitrile and 10%
formic acid in water. The sequences of the synthetic peptides matched
those of the peptides expected to be created by endoproteinase cleavage
of the U1 snRNP. All peptides that corresponded to cleavage products of
a distinct proteinase (endoproteinase Lys-C, Asp-N, Glu-C, or trypsin)
were combined; this resulted in four peptide mixtures. These solutions
were then diluted with water to a volume of 250 l, resulting in
concentrations between 0.03–0.13 g/l each peptide. 5 l of each of
these solutions was combined with 45 l of HEPES buffer (50 mM, pH
8.5). Thereafter, 4 l of propionyl-N-oxysuccinimide (0.15 M in Me2SO)
or nicotinoyl-N-oxysuccinimide (0.15 M in Me2SO) was added. The mix-
ture was incubated at 25 °C for 1 h. To stop the reaction, 4 l of
ammonium chloride (1 M) was added, and the solution was incubated for
15 min at room temperature. To hydrolyze reaction side products with
hydroxyl groups (18, 19), the pH was raised to 12 with NaOH (1 M) for
10 min. The solution was then neutralized by the addition of the same
amount of HCl (1 M). 0.5–2 l of this solution was added to the digest of
the human U1 snRNP.
Denaturation and Digestion of the Human U1 snRNP—2.5–4 l of
the U1 snRNP (0.5 mg/ml (20), dissolved in 20 mM Tris-HCl, pH 7.9, 1.5
mM MgCl2, 150 mM KCl, 0.5 mM dithioerythritol, 0.5 mM phenylmeth-
ylsulfonyl fluoride), purified essentially according to the methods of
Bach et al. (21) and containing its complete set of proteins (see Fig. 1 for
a Coomassie-stained electrophoresis gel), were mixed with 20 l of 6 M
guanidinium hydrochloride. 1 l of dithiothreitol (1 mg/ml) was added,
and the solution was incubated at 60 °C for 45 min. The solution was
then diluted with 180 l of 25 mM HEPES buffer (pH 8.5), after which
40 l of endoproteinase Lys-C (0.05 g/ml), trypsin, endoproteinase
Glu-C, or endoproteinase Asp-N were added, and the digests were
incubated at 37 °C overnight.
Labeling of the Digest with [12C]Propionyl-N-oxysuccinimide or
[12C]Nicotinoyl-N-oxysuccinimide—4 l of propionyl-N-oxysuccinimide
or nicotinoyl-N-oxysuccinimide (0.15 M in Me2SO) was added to 75 l of
the endoproteinase digest (see above), and the solution was incubated
at 25 °C for 1 h. Subsequently, 4 l of ammonium chloride (1 M) was
added, and the mixture was incubated for a further 15 min. The pH was
raised to 12 with NaOH (1 M) for 10 min, and the solution was then
neutralized with the same amount of HCl (1 M).
Capillary Liquid Chromatography and MALDI Target Preparation—
Separation of the peptides was achieved with a capillary liquid chro-
matography system (Ultimate, LC Packings) and a reversed-phase col-
umn (LC Packings Pepmap reversed-phase C18 column; 15 cm
length  75 m inner diameter). 25 l of the peptide solution was
injected and the peptides were trapped on a short reversed-phase col-
umn. For the separation of the peptides, the solvents A (0.05% TFA) and
B (80% acetonitrile, 0.04% TFA) were used with a linear gradient from
10 to 100% B in 30 min with subsequent 20-min isocratic intervals at
100% B. The eluting peptides were spotted robotically onto a 192-well
MALDI sample plate and mixed with a matrix solution (5 mg/ml of
-cyano-4-hydroxycinnamic acid dissolved in 50% acetonitrile, 0.1%
TFA) during the spotting process. The sample spots were dried at
room temperature.
Tandem Time-of-flight Mass Spectrometry—Mass spectrometric
analysis was performed on a 4700 Proteomics Analyzer from Applied
Biosystems (Framingham, MA) equipped with a neodymium-YAG (yt-
trium-aluminum-garnet) laser that produces pulsed power at 355 nm at
pulse rates of 200 Hz. Mass analysis was performed using the positive
reflector mode with a deflection cutoff range ofm/z 700. 5000 laser shots
were accumulated to produce a single spectrum (Fig. 1). Subsequently,
high energy MALDI-TOF/TOF collision-induced dissociation spectra
were recorded on selected ions from the same sample spot. The collision
energy was 2 keV. Air was used as the collision gas.
RESULTS
Peptide Selection—Fig. 2 shows a schematic summary of the
method we used for the determination of the stoichiometry of
the U1 snRNP. The complex was denatured and digested com-
pletely with an endoproteinase. The proteolytic peptides were
then labeled with an amine-specific 12C isotope-coded tag (18,
FIG. 1. Coomassie-stained one-dimensional SDS gel of the U1
snRNP.
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19). Reference peptides were selected from the data base, syn-
thesized, and labeled with a 13C isotope-coded tag. Mass spec-
trometric comparison of the intensities of the 12C- and 13C-
labeled peptide pairs allows the absolute quantification of the
peptides. The ratio of the absolute quantities of peptides re-
sulting from different proteins corresponds to the stoichiometry
of the proteins in the complex. In this study, we selected two
peptides/protein from the protein sequences in the NCBI data
base for the absolute quantification of all ten U1 proteins. The
sequences of the peptides are shown in Tables I and II. We used
FIG. 2. Analytical strategy illustrated for a 2:1:1 complex.
Stoichiometry Determination of the U1 Spliceosomal snRNP2538
 at M
ax Planck Inst.Biophysikalische Chem
ie,O
tto Hahn Bibl,Pf.2841,37018 G
oettingen on M









the following selection criteria for the reference peptides. (i) No
peptides starting with proline or glutamic acid were chosen,
considering the possibility of incomplete cleavage by some en-
doproteinases (e.g. trypsin) before these amino acids. (ii) Amino
acids that can be oxidized or transformed were avoided, such as
methionine and tryptophan (which are easily oxidized) and
N-terminal glutamine (which can be transformed into pyroglu-
tamic acid). All the peptides chosen fulfill these requirements,
except for the methionine-containing peptides 3–9 of SmD1 and
peptides 73–80 and 13–23 of SmE. Peptides 10–20 and 66–86
of SmD1 and 81–92 of SmE, which would fit the criteria, could
not be synthesized in sufficient purity. All reference peptides
correspond to peptides that are expected to be produced from
the spliceosomal proteins by endoproteinase digestion. As
shown in Tables I and II, most peptides are created by endo-
proteinase Lys-C digestion. Alternatives were trypsin, endo-
proteinase Glu-C, and Asp-N.
Peptide Derivatization—There are two possibilities for the
incorporation of stable isotopes into peptides: peptide synthesis
using isotope-coded amino acids (such as [15N]-, [18O]-leucine)
(8) or derivatization of their side chains with isotope-coded
reagents (22). Munchbach et al. (23) describes the advantages
of amine-specific isotope-coded reagents, such as d0/d4 nicoti-
noyl-N-oxysuccinimide carrying a fixed positive charge and
increasing the mass spectrometric response for labeled pep-
tides significantly, compared with the acetylated peptide as
well as with their unlabeled counterpart. The increase in mass
spectrometric response is most pronounced for small peptides
(up to 10 amino acids), which can also be synthesized more
reliably. The use of nicotinoylation may therefore result in an
increase in sensitivity for the absolute quantification and stoi-
chiometry determination, even for protein complexes that can
only be isolated in low quantities.
Determination of Optimal Conditions for Denaturation and
Digestion—To determine the correct stoichiometry with this
method, complete denaturation and digestion needs to be
achieved for the U1 snRNP. Initially, urea was used for the
denaturation of the complex. Urea is tolerated by several en-
doproteinases up to a concentration of 4 M, which allowed the
digestion of the denatured protein complexes without prior
dilution or dialysis (9). However, even with a concentration of 8
M urea, complete denaturation of the U1 snRNP was not
achieved (data not shown). Therefore, 5 M guanidinium hydro-
chloride (GHCl) was tested. Because most endoproteinases al-
ready show a significant loss of activity at a concentration of 1
M, the denatured complex was diluted to 0.5 M GHCl with
HEPES buffer. Subsequently, the enzyme was added and in-
cubated overnight. After labeling with a 12C amine-specific tag,
the digest was spiked with the synthetic peptides, which were
derivatized with a 13C amine-specific tag. 0.36 g of the com-
plex was used in each experiment; assuming a hypothetical 1:1
stoichiometry of all complex constituents, this would corre-
spond to 1.7 pmol of the complex. Approximately the same
molar amounts of the reference peptides were added, which
should therefore theoretically result in a similar intensity of
the 12C- and 13C-labeled peptides, supposing the complex to
have been pure and denaturation and digestion to have been
complete. Figs. 3 and 4 show the MALDI-TOF mass spectra of
the peptides acquired after liquid chromatographic separation,
which demonstrated a similar intensity of the isotopic
peptide pairs.
Stoichiometry Determination Using Propionyl-N-oxysuccin-
imide—Table I summarizes the results of two independent
experiments for the absolute quantification of the U1 proteins
using propionyl-N-oxysuccinimide, using 0.36 g of the com-
plex/experiment. Half of all the peptides, however, could not be
detected because of their low mass spectrometric response.
Peptides from the proteins U1–70 K, U1-A, SmD1, SmD2,
SmD3, SmE, and SmG showed absolute amounts in the range
of 1.25–1.67 pmol, suggesting 1:1 stoichiometries of these pro-
teins in the complex. The observed deviations of approximately
16% may be due to variations in sample handling, such as
pipetting of peptide samples and dilutions. Peptides 38–50 of
SmD2 showed a very high amount (12.4 pmol), which may have
been due to solubility problems of the reference peptide. Con-
centrations below 0.069 pmol were found for peptides 90–99 of
SmD3, which was attributed to arginine dimethylation of
Arg-97 (12).
Stoichiometry Determination Using Nicotinoyl-N-oxysuccin-
imide—To quantify all the proteins in the complex, the exper-
iments were repeated with the same absolute amounts of the
U1 snRNP as described above, replacing propionyl-N-oxysuc-
TABLE I
Quantification of human U1 snRNP labeled with [12C]propionyl-N-oxysuccinimide
This table summarizes the results of two independent experiments for the absolute quantification of the human U1 snRNP denatured, digested
with endoproteinase Lys-C, Glu-C or trypsin, and labeled with [12C]propionyl-N-oxysuccinimide. Absolute quantification was achieved by the
addition of synthetic peptides labeled with [13C]propionyl-N-oxysuccinimide. Two peptides were used for the quantification of most proteins.
Quantification was compromised for some peptides of the Sm proteins because of methylation of arginine residues (SmB, SmD3).
Protein Peptide
Experiment 1 Experiment 2
Enzyme
pmol Mean value pmol Mean value
U1–70K LRREFEVYGPIK (104–118) 1.46 1.47 1.43 1.44 Lys-C
TLFVARVNYDTTESK (119–130) 1.48 1.44 Lys-C
U1-C TTAAFQQGK (53–61) Not detected Lys-C
DYYQK (36–40) Not detected Lys-C
U1-A GTFVERDRK (99–107) 1.53 1.53 1.25 1.25 Lys-C
SQETPATK (115–122) Not detected Lys-C
SmB KRVLGLVLLRGE (64–75) Not detected Glu-C
VLGLVLLR (66–73) Not detected Trypsin
VPLAGAAGGPGIGR (98–108) Not detected Trypsin
SmD1 LVRFLMK (3–9) 1.57 1.57 1.38 1.38 Lys-C
SmD2 DRYISK (93–98) 1.46 1.46 1.44 1.44 Lys-C
NNTQVLINCRNNK (38–50) 12.34 12.79 Lys-C
SmD3 NQGSGAGRGK (90–99)  0.0783  0.0688 Lys-C
VAQLEQVYIR (55–64) 1.49 1.49 1.50 1.50 Trypsin
SmE QLGRIMLK (73–80) 1.50 1.50 1.67 1.67 Lys-C
VMVQPINLIFR (13–23) Not detected Trypsin
SmF YIDGALSGHLGE (9–17) Not detected Glu-C
CNNVLYIR (65–73) Not detected Trypsin
SmG AHPPELK (4–10) 1.60 1.60 1.30 1.30 Lys-C
HVQGILR (26–32) Not detected Trypsin
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cinimide with nicotinoyl-N-oxysuccinimide (Table II). In this
case, all the peptides were detected; in particular, small pep-
tides showed a significant increase in detectability as compared
with propionyl-N-oxysuccinimide. One peptide of SmG (4–10,
sequence: (K) AHPPELK), which is created by complete diges-
tion with endoproteinase Lys-C or trypsin, was quantified in
TABLE II
Quantification of human U1 snRNP labeled with [12C]nicotinoyl-N-oxysuccinimide
This table summarizes the results of two independent experiments for the absolute quantification of the human U1 snRNP denatured, digested
with endoproteinase Lys-C, Glu-C, trypsin, or Asp-N, and labeled with [12C]nicotinoyl-N-oxysuccinimide. Absolute quantification was achieved by
the addition of synthetic peptides labeled with [13C]nicotinoyl-N-oxysuccinimide. Two peptides were used for the quantification of most proteins.
Quantification was compromised for some peptides of the Sm proteins because of methylation of arginine residues (SmB, SmD3).
Protein Peptide
Experiment 1 Experiment 2
Enzyme
pmol Mean value pmol Mean value
U1–70K LRREFEVYGPIK (104–118) 1.83 1.67 1.52 1.53 Lys-C
TLFVARVNYDTTESK (119–130) 1.51 1.54 Lys-C
U1-C TTAAFQQGK (53–61) 1.38 1.59 1.25 1.32 Lys-C
DYYQK (36–40) 1.79 1.38 Lys-C
U1-A GTFVERDRK (99–107) 1.53 1.41 1.20 1.40 Lys-C
SQETPATK (115–122) 1.30 1.59 Lys-C
SmB KRVLGLVLLRGE (64–75) 1.65 1.48 1.38 1.37 Glu-C
VLGLVLLR (66–73) 1.35 1.36 Trypsin
VPLAGAAGGPGIGR (95–108)  0.0065  0.0054 Trypsin
SmD1 LVRFLMK (3–9) 1.57 1.57 1.38 1.38 Lys-C
SmD2 DRYISK (93–98) 1.88 1.86 1.51 1.65 Lys-C
NNTQVLINCRNNK (38–50) 11.51 13.50 Lys-C
DSVIVVLRNPLIAGK (104–118) 1.84 1.79 Asp-N
SmD3 NQGSGAGRGK (90–99)  0.0087 1.40  0.098 1.60 Lys-C
VAQLEQVYIR (55–64) 1.40 1.60 Trypsin
SmE QLGRIMLK (73–80) 1.73 1.55 1.53 1.51 Lys-C
VMVQPINLIFR (13–23) 1.35 1.48 Trypsin
SmF YIDGALSGHLGE (9–17) 0.050 1.71 0.035 1.23 Glu-C
CNNVLYIR (65–73) 1.71 1.23 Trypsin
SmG AHPPELK (4–10) 1.45/1.31 1.50 1.55/1.67 1.51 Lys-C/Trypsin
HVQGILR (26–32) 1.54 1.46 Trypsin
FIG. 3.MALDI-TOF mass spectra used for the absolute quantification of spliceosomal proteins U1–70 K, SmE, D2, D1, and G of the
U1 snRNP. The U1 spliceosomal snRNP was denatured and then digested completely with endoproteinase Lys-C as described under “Experi-
mental Procedures.” The resulting peptides were labeled with [12C]propionyl-N-oxysuccinimide. Known amounts of synthetic peptides, labeled with
the corresponding 13C isotope-coded amine-specific tag, were added (*Reference). MALDI-TOF mass spectrometry was used to absolutely quantify
the proteins in the U1 spliceosomal snRNP.
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both digests. Quantification of this peptide in trypsin and en-
doproteinase Lys-C digests resulted in similar quantities (Ta-
ble II), which suggests that the digestion was complete. In
similarity to the experiments with propionyl-N-oxysuccinim-
ide, mean absolute quantities of 1.40–1.86 pmol (Experiment
1) and 1.23–1.65 pmol (Experiment 2) were measured for most
peptides. For peptides 95–108 of SmB and 90–99 of SmD3,
quantities below 0.01 pmol were determined. This was ascribed
to dimethylation of arginine 97 of SmD3 and arginine 108 of
SmB (12). For peptides 9–17 of SmF, a quantity of 0.035–0.05
pmol was found. This peptide contains aspartic acid, which is
also cleaved by endoproteinase Glu-C to a lesser extent. For
peptides 38–50 of SmD2, very high quantities (11.5–13.5 pmol)
were found. These data also demonstrated that one peptide/
protein may be insufficient for the reliable absolute quantifi-
cation of a protein. A third peptide-(104–118) from SmD2 was
therefore quantified, resulting in 1.79–1.84 pmol, which is
comparable with the quantity of peptides 93–98 (1.65–1.88
pmol).
DISCUSSION
Recently, we described a method for the determination of the
stoichiometry of protein complexes. Absolute quantification of
the complex constituents was achieved by comparing the areas
of fluorescently labeled peptides resulting from different pro-
teins in the fluorescence chromatogram. This method was used
for the determination of the stoichiometry of the complex of
hFc1 and sFcRIII (9). The method allows relatively fast stoi-
chiometry determination of complexes consisting of a moderate
number of proteins. Although cysteine-specific rather than
amine-specific labeling reduced significantly the complexity of
the fluorescently labeled peptide mixture resulting from hFc1
and sFcRIII, the number of peptides resulting from very large
multiprotein complexes may still be too high to allow a good
separation. Therefore, we tested the strategy depicted in Fig. 2
for stoichiometry determination of multiprotein complexes. Be-
cause reference peptides have to be synthesized for this ap-
proach, this method is more time-consuming than the fluores-
cence method; however, it overcomes several limitations for the
analysis of large multiprotein complexes. First of all, it is
absolutely compatible with multidimensional separations.
Losses of peptides during the transfer from the first to the
second dimension have no influence on the absolute quantifi-
cation, because the 13C-labeled synthetic reference peptides
show chromatographic behavior identical to that of their 12C-
labeled counterparts. Furthermore, even poorly separated pep-
tides in the chromatogram can be quantified, because the quan-
tification is based on the comparison of the mass spectrometric
intensities belonging to the isotopic peptide pairs. A similar
approach was suggested for absolute quantification in proteom-
ics, using isotope-coded affinity tag-labeled idiotypic synthetic
reference peptides as internal standards (22).
However, several circumstances should be considered when
FIG. 4. MALDI-TOF mass spectra used for the absolute quantification of spliceosomal proteins SmG, U1-C, SmE, and SmB of the
U1 snRNP. The U1 spliceosomal snRNP was denatured and then digested completely with endoproteinase Lys-C (U1-C, SmG), trypsin (SmG,
SmE) and endoproteinase Glu-C (SmB) as described under “Experimental Procedures.” The resulting peptides were labeled with [12C]nicotinoyl-
N-oxysuccinimide. Known amounts of synthetic peptides, labeled with the corresponding 13C isotope-coded tag were added (*Reference). MALDI-
TOF mass spectrometry was used to absolutely quantify the proteins in the U1 spliceosomal snRNP.
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using this approach for absolute protein quantification. Com-
plete denaturation and digestion of the complex is a prerequi-
site for absolute quantification and stoichiometry determina-
tion. Furthermore, because unmodified synthetic peptides are
used for quantification, unexpected post-translational modifi-
cations of the proteolytic peptides can falsify the result in
quantification of the protein. The use of absolute quantification
on a proteome-wide scale may therefore still be problematic.
Multiprotein complexes, however, consist of a moderate num-
ber of proteins, which are usually better characterized. Another
issue is that of miscleavage by endoproteinases, such as chy-
motryptic activity in trypsin or endoproteinase Glu-C cleavage
at aspartic acid.
Therefore, we used in this study two or more peptides/pro-
tein for the absolute quantification of most proteins. We found
similar absolute quantities for all ten proteins, suggesting
equal stoichiometries of all ten proteins in the U1 snRNP,
including U1-C. For quantification of the SmB protein, only
peptides derived from sequences common to both SmB and
SmB were used. Consequently, there is only one type of SmB
protein in the Sm core, and SmB can be replaced by SmB or
vice versa. Because Coomassie-stained gels of electrophoreti-
cally separated snRNP proteins always show the two proteins
SmB and SmB as two bands of equal intensity (see Fig. 1), the
two proteins are present in approximately similar amounts.
The 1:1 stoichiometry of the Sm proteins is in good agreement
with a model proposing that the Sm proteins form a heptamer
ring with a single copy of each Sm protein in the snRNPs (14,
15). A 1:1 stoichiometry is also in best agreement with the
three-dimensional structure of U1 snRNP derived from single
particle electron cryomicroscopy (16). However, the stoichio-
metric analysis does not exclude the possibility that two kinds
of U1 snRNP are present in equal amounts: one with two copies
of the protein U1-C protein and the other with none. Neverthe-
less, this possibility can be excluded, because the ion exchange
chromatography used here to purify U1 snRNP separated U1
snRNPs lacking protein U1-C from those containing it (Ref. 21
and data not shown). The method described here should there-
fore be well suited for the determination of the stoichiometric
composition of a variety of snRNPs and (spliceosomal) multi-
protein complexes.
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